4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000899243-22-032164
Chief Executive Officer sold 1,264 shares at $5.51 ($6,965)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-09-26 | Sale | −1,264 | $5.51 | $6,965 | 253,520 | D |
| Open-market sales · 1,264 sh · avg $5.51 · $6,965 | |||||||
Loading xslF345X03/doc4.xml…